KNAT6 Antibody

Here’s a structured collection of FAQs tailored for researchers working with KNAT6 antibodies in plant developmental biology, synthesized from peer-reviewed studies and experimental methodologies:

Advanced Methodological Considerations

Resolving contradictory expression data in floral abscission studies

• Problem: KNAT6 shows both positive (IDA pathway) and negative (BP-mediated) regulatory roles

• Solution:

  • Conduct tissue-specific ChIP-qPCR (AZ vs. non-AZ regions)

  • Use brm-3 bp-9 double mutants to decouple chromatin remodeling effects

  • Quantify H3K4me3 levels at promoter vs. intronic regions (Fig.6B-C)

Optimizing IHC protocols for meristematic tissues

• Challenge: High polysaccharide content in shoot apices

• Protocol adjustments:

  • Fixation: 4% paraformaldehyde + 0.1% Triton X-100 (2 hr)

  • Antigen retrieval: 10 mM citrate buffer (pH 6.0), 95°C, 20 min

  • Blocking: 5% BSA + 2% goat serum (prevents non-specific binding in dense SAMs)

Technical Validation Framework

Interpreting KNAT6 antibody performance across genetic backgrounds

Mechanistic Studies

Designing multiplex assays for KNAT6 interactome analysis

• Step 1: Co-IP with BRM/BP proteins using:

  • 50 mM HEPES (pH 7.4), 150 mM NaCl, 0.5% NP-40

  • Protease inhibitor cocktail (include 1 mM PMSF)

• Step 2: Validate complexes via:

  • EMSA with TGAC motif probes (Fig.7B)

  • Phos-tag gels to detect phosphorylation states

Addressing epigenetic regulation discrepancies

• Conflict: H3K4me3 increases in brm-3 but no H3K27me3 changes

• Resolution strategy:

  • Profile histone demethylases (e.g., LDL3, REF6) in SAMs

  • Use brm-3 utx double mutants to test compensatory mechanisms

  • Perform ATAC-seq to map chromatin accessibility changes